Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 34.39% vs -4.22% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 183.41% vs -390.00% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 187.13% vs -354.14% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is -71.96% vs 118.37% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Panacea Biotec With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -4.96% vs 19.68% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 34.39% vs -4.22% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 404.78% vs 342.31% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 183.41% vs -390.00% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 173.37% vs 120.62% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 187.13% vs -354.14% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -49.15% vs -1.67% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -71.96% vs 118.37% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025